- Home
- ABUS vs AXL Comparison
ABUS vs AXL Comparison
Compare ABUS & AXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- AXL
- Stock Information
- Founded
- ABUS 2005
- AXL 1994
- Country
- ABUS United States
- AXL United States
- Employees
- ABUS N/A
- AXL N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- AXL Auto Parts:O.E.M.
- Sector
- ABUS Health Care
- AXL Consumer Discretionary
- Exchange
- ABUS Nasdaq
- AXL Nasdaq
- Market Cap
- ABUS 592.8M
- AXL 487.5M
- IPO Year
- ABUS N/A
- AXL 1999
- Fundamental
- Price
- ABUS $3.24
- AXL $3.39
- Analyst Decision
- ABUS Strong Buy
- AXL Hold
- Analyst Count
- ABUS 4
- AXL 8
- Target Price
- ABUS $5.50
- AXL $6.38
- AVG Volume (30 Days)
- ABUS 1.3M
- AXL 2.7M
- Earning Date
- ABUS 05-05-2025
- AXL 05-02-2025
- Dividend Yield
- ABUS N/A
- AXL N/A
- EPS Growth
- ABUS N/A
- AXL N/A
- EPS
- ABUS N/A
- AXL 0.29
- Revenue
- ABUS $6,171,000.00
- AXL $6,124,900,000.00
- Revenue This Year
- ABUS $14.57
- AXL N/A
- Revenue Next Year
- ABUS $15.84
- AXL N/A
- P/E Ratio
- ABUS N/A
- AXL $11.85
- Revenue Growth
- ABUS N/A
- AXL 0.75
- 52 Week Low
- ABUS $2.63
- AXL $3.00
- 52 Week High
- ABUS $4.72
- AXL $7.98
- Technical
- Relative Strength Index (RSI)
- ABUS 50.09
- AXL 37.27
- Support Level
- ABUS $2.71
- AXL $3.20
- Resistance Level
- ABUS $3.32
- AXL $3.36
- Average True Range (ATR)
- ABUS 0.21
- AXL 0.24
- MACD
- ABUS 0.00
- AXL 0.05
- Stochastic Oscillator
- ABUS 63.86
- AXL 48.13
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About AXL American Axle & Manufacturing Holdings Inc.
American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.